These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 12541013)

  • 1. Polymorphisms of the alpha-synuclein promoter: expression analyses and association studies in Parkinson's disease.
    Holzmann C; Krüger R; Saecker AM; Schmitt I; Schöls L; Berger K; Riess O
    J Neural Transm (Vienna); 2003 Jan; 110(1):67-76. PubMed ID: 12541013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. alpha-Synuclein promoter confers susceptibility to Parkinson's disease.
    Pals P; Lincoln S; Manning J; Heckman M; Skipper L; Hulihan M; Van den Broeck M; De Pooter T; Cras P; Crook J; Van Broeckhoven C; Farrer MJ
    Ann Neurol; 2004 Oct; 56(4):591-5. PubMed ID: 15455394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the coding and the 5' flanking regions of the alpha-synuclein gene in patients with Parkinson's disease.
    Pastor P; Muñoz E; Ezquerra M; Obach V; Martí MJ; Valldeoriola F; Tolosa E; Oliva R
    Mov Disord; 2001 Nov; 16(6):1115-9. PubMed ID: 11748744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. alpha-Synuclein gene haplotypes are associated with Parkinson's disease.
    Farrer M; Maraganore DM; Lockhart P; Singleton A; Lesnick TG; de Andrade M; West A; de Silva R; Hardy J; Hernandez D
    Hum Mol Genet; 2001 Aug; 10(17):1847-51. PubMed ID: 11532993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration in alpha-synuclein mRNA expression in Parkinson's disease.
    Kingsbury AE; Daniel SE; Sangha H; Eisen S; Lees AJ; Foster OJ
    Mov Disord; 2004 Feb; 19(2):162-70. PubMed ID: 14978671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a risk haplotype of the alpha-synuclein gene in Japanese with sporadic Parkinson's disease.
    Kobayashi H; Ujike H; Hasegawa J; Yamamoto M; Kanzaki A; Sora I
    Mov Disord; 2006 Dec; 21(12):2157-64. PubMed ID: 17078049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple regions of alpha-synuclein are associated with Parkinson's disease.
    Mueller JC; Fuchs J; Hofer A; Zimprich A; Lichtner P; Illig T; Berg D; Wüllner U; Meitinger T; Gasser T
    Ann Neurol; 2005 Apr; 57(4):535-41. PubMed ID: 15786467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the gamma-synuclein gene in German Parkinson's disease patients.
    Krüger R; Schöls L; Müller T; Kuhn W; Woitalla D; Przuntek H; Epplen JT; Riess O
    Neurosci Lett; 2001 Sep; 310(2-3):191-3. PubMed ID: 11585599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-synuclein mRNA expression in sporadic Parkinson's disease.
    Tan EK; Chandran VR; Fook-Chong S; Shen H; Yew K; Teoh ML; Yuen Y; Zhao Y
    Mov Disord; 2005 May; 20(5):620-3. PubMed ID: 15719423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. alpha-Synuclein locus triplication causes Parkinson's disease.
    Singleton AB; Farrer M; Johnson J; Singleton A; Hague S; Kachergus J; Hulihan M; Peuralinna T; Dutra A; Nussbaum R; Lincoln S; Crawley A; Hanson M; Maraganore D; Adler C; Cookson MR; Muenter M; Baptista M; Miller D; Blancato J; Hardy J; Gwinn-Hardy K
    Science; 2003 Oct; 302(5646):841. PubMed ID: 14593171
    [No Abstract]   [Full Text] [Related]  

  • 11. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.
    Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H
    J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-synuclein promoter haplotypes and dementia in Parkinson's disease.
    De Marco EV; Tarantino P; Rocca FE; Provenzano G; Civitelli D; De Luca V; Annesi F; Carrideo S; Cirò Candiano IC; Romeo N; Nicoletti G; Marconi R; Novellino F; Morelli M; Quattrone A; Annesi G
    Am J Med Genet B Neuropsychiatr Genet; 2008 Apr; 147(3):403-7. PubMed ID: 17918232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease.
    Conway KA; Harper JD; Lansbury PT
    Nat Med; 1998 Nov; 4(11):1318-20. PubMed ID: 9809558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Essential tremor is not associated with alpha-synuclein gene haplotypes.
    Pigullo S; Di Maria E; Marchese R; Bellone E; Gulli R; Scaglione C; Battaglia S; Barone P; Martinelli P; Abbruzzese G; Ajmar F; Mandich P
    Mov Disord; 2003 Jul; 18(7):823-6. PubMed ID: 12815663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of allelic variation at the NACP-Rep1 repeat upstream of the alpha-synuclein gene (SNCA) on transcription in a cell culture luciferase reporter system.
    Chiba-Falek O; Nussbaum RL
    Hum Mol Genet; 2001 Dec; 10(26):3101-9. PubMed ID: 11751692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation screening in exons 3 and 4 of alpha-synuclein in sporadic Parkinson's and sporadic and familial dementia with Lewy bodies cases.
    El-Agnaf OM; Curran MD; Wallace A; Middleton D; Murgatroyd C; Curtis A; Perry R; Jaros E
    Neuroreport; 1998 Dec; 9(17):3925-7. PubMed ID: 9875730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on exons 3 and 4 of alpha-synuclein gene in Chinese familial Parkinson disease patients].
    Chen X; Liu YT; Li JR; Chen L; Xu YM; Pan YH; Meng XH; Xing SH
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Dec; 20(6):536-8. PubMed ID: 14669226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?
    Olanow CW; Brundin P
    Mov Disord; 2013 Jan; 28(1):31-40. PubMed ID: 23390095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parkinson's disease genetic mutations increase cell susceptibility to stress: mutant alpha-synuclein enhances H2O2- and Sin-1-induced cell death.
    Jiang H; Wu YC; Nakamura M; Liang Y; Tanaka Y; Holmes S; Dawson VL; Dawson TM; Ross CA; Smith WW
    Neurobiol Aging; 2007 Nov; 28(11):1709-17. PubMed ID: 16978743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased susceptibility to sporadic Parkinson's disease by a certain combined alpha-synuclein/apolipoprotein E genotype.
    Krüger R; Vieira-Saecker AM; Kuhn W; Berg D; Müller T; Kühnl N; Fuchs GA; Storch A; Hungs M; Woitalla D; Przuntek H; Epplen JT; Schöls L; Riess O
    Ann Neurol; 1999 May; 45(5):611-7. PubMed ID: 10319883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.